Overview
Gilead Sciences, Inc., based in the United States, operates primarily within the biopharmaceutical industry, focusing on the discovery, development, and commercialization of innovative therapies. Renowned for its significant contributions to antiviral drugs, especially those treating HIV/AIDS and hepatitis C, Gilead has expanded its portfolio to include treatments in oncology and inflammatory and respiratory diseases. Key projects have included the development of remdesivir, one of the first drugs approved to treat COVID-19, underlining the company’s pivotal role in responding to global health crises. Gilead continues to advance its pipeline through robust R&D initiatives and strategic acquisitions, ensuring a sustained impact on healthcare markets globally while enhancing its therapeutic offerings.
AI+ Ask Fintel’s AI assistant about Gilead Sciences, Inc..
Thinking about good questions…
Basic Stats
The Factor Analysis chart (below right) shows a view of Gilead Sciences, Inc. from a variety of lenses. Each factor shows how well the company ranks against all other companies in the Fintel global investing universe. Factor scores range from zero to 100, with 100 being most desirable, and 50 being average.
For example, a company with a Value Score of 100 would be the most undervalued company in our database. A company with a Value Score of zero would be the most overvalued.
| Market Cap | |
| EV | |
| Shares Out. | 1,242.00 MM |
| Earnings Date | |
| EPS (TTM) | 5.08 |
| Dividend Yield | |
| Ex-Dividend Date | 2025-09-15 |
| Borrow Rate | |
| Short Shares Avail. | |
| Short Interest | |
| Short Float | |
| Days to Cover | |
| Risk Free Rate | 4.17 % |
| Price Change (1 yr) | |
| Volatility (1 yr) | |
| Beta | |
| Sharpe Ratio (1 yr) | |
| Sortino Ratio (1 yr) |
| PE Ratio | |
| Price/Book | |
| Price/TBV | |
| Book/Market | |
| EBIT/EV | |
| EBIT(3yr avg)/EV | |
| ROA | 0.12 |
| ROE | 0.35 |
| ROIC | 0.14 |
| CROIC | 0.05 |
| OCROIC | 0.22 |
| Implied Volatility | |
| Put/Call OI Ratio |
| Growth | 63.05 /100 |
| Profitability | 85.94 /100 |
| Quality Score | 73.22 /100 |
| Value Score | |
| Momentum Score | |
| Stability (Low Vol) Score | |
| Analyst Sentiment | |
| Fund Sentiment | 36.27 /100 |
| Insider Sentiment | |
| Officer Sentiment | |
| Dividend Score | |
| QVM Score | |
| Piotroski F-SCORE | 9.00 /9 |
Factor Scores range from 0 to 100, with 100 being most desirable. Larger circles are better. In situations where we have no data (e.g. no insider trades), we plot the score at 50 to avoid penalizing companies. However, a company that does not pay dividends will get a Dividend Score of Zero. Additionally, we inverted volatility to create a "stability" metric which is better when higher.
Price Target
The average one-year price target for Gilead Sciences, Inc. is CLP103,983.86. The forecasts range from a low of CLP78,429.40 to a high of CLP129,263.63. A stock’s price target is the price at which analysts consider it fairly valued with respect to its projected earnings and historical earnings. Analysts typically set price targets that correspond to their buy or sell recommendations.
Update Frequency: Monthly
Stock Upgrades/Downgrades
This card shows analyst upgrades/downgrades for Gilead Sciences, Inc.. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.
The standard analyst ratings are generally as follows:
- Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
- Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
- Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.
When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.
The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.
| Date | Analyst | Prior | Latest Recommendation |
Action |
|---|---|---|---|---|
| 2025-02-12 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-02-12 | BMO Capital | Outperform | Outperform | Maintains |
| 2025-02-12 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2025-02-12 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-09-09 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-11-21 | Mizuho | Outperform | Outperform | Maintains |
| 2025-03-04 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-11-21 | UBS | Neutral | Neutral | Maintains |
| 2024-08-15 | Truist Securities | Hold | Hold | Maintains |
| 2024-08-15 | Needham | Hold | Reiterate | |
| 2024-11-07 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-11-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-11-07 | Wells Fargo | Overweight | Overweight | Maintains |
| 2024-11-07 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2024-11-07 | Goldman Sachs | Neutral | Neutral | Maintains |
| 2024-11-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-11-07 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-11-07 | Baird | Neutral | Neutral | Maintains |
| 2024-11-07 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-11-07 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-11-07 | Needham | Hold | Reiterate | |
| 2025-01-10 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2024-10-21 | Leerink Partners | Market Perform | Outperform | Upgrade |
| 2024-09-16 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-10-07 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-10-07 | Wells Fargo | Equal-Weight | Overweight | Upgrade |
| 2024-10-17 | BMO Capital | Outperform | Outperform | Maintains |
| 2024-10-17 | Bernstein | Outperform | Initiate | |
| 2024-11-14 | Citigroup | Buy | Initiate | |
| 2025-02-03 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-11-15 | Wolfe Research | Outperform | Initiate | |
| 2024-11-08 | Truist Securities | Hold | Hold | Maintains |
| 2024-11-08 | Maxim Group | Buy | Hold | Downgrade |
| 2024-10-29 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-08-09 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2024-08-09 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-08-09 | BMO Capital | Outperform | Outperform | Maintains |
| 2023-01-03 | RBC Capital | Outperform | Sector Perform | Downgrade |
| 2022-12-13 | B of A Securities | Neutral | Reiterate | |
| 2022-12-01 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-11-08 | Cowen & Co. | Outperform | Maintains | |
| 2022-11-08 | Mizuho | Buy | Maintains | |
| 2022-11-01 | SVB Leerink | Market Perform | Maintains | |
| 2022-10-31 | Maxim Group | Buy | Maintains | |
| 2022-10-31 | Barclays | Underweight | Equal-Weight | Upgrade |
| 2022-10-28 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-28 | RBC Capital | Outperform | Maintains | |
| 2022-10-28 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-10-28 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2022-10-28 | Truist Securities | Hold | Buy | Upgrade |
| 2022-10-13 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-10-12 | Barclays | Underweight | Maintains | |
| 2022-10-04 | JP Morgan | Neutral | Overweight | Upgrade |
| 2022-09-15 | Truist Securities | Hold | Maintains | |
| 2022-09-13 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-07-26 | Piper Sandler | Neutral | Maintains | |
| 2022-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-07-13 | Cantor Fitzgerald | Neutral | Initiate | |
| 2022-05-23 | SVB Leerink | Market Perform | Initiate | |
| 2022-05-17 | Piper Sandler | Neutral | Maintains | |
| 2022-04-29 | BMO Capital | Market Perform | Maintains | |
| 2022-04-29 | Piper Sandler | Neutral | Maintains | |
| 2022-04-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-04-12 | RBC Capital | Outperform | Maintains | |
| 2022-04-04 | Piper Sandler | Neutral | Maintains | |
| 2022-03-22 | Wells Fargo | Equal-Weight | Maintains | |
| 2022-03-10 | Barclays | Underweight | Maintains | |
| 2022-03-08 | RBC Capital | Outperform | Maintains | |
| 2022-02-28 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2022-02-08 | Mizuho | Buy | Maintains | |
| 2022-02-02 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-01-28 | Argus Research | Hold | Buy | Upgrade |
| 2022-01-18 | Morgan Stanley | Equal-Weight | Maintains | |
| 2022-01-06 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2021-12-09 | Wells Fargo | Equal-Weight | Initiate | |
| 2021-12-06 | Goldman Sachs | Neutral | Initiate | |
| 2021-10-29 | SVB Leerink | Outperform | Maintains | |
| 2021-10-12 | Morgan Stanley | Overweight | Maintains | |
| 2021-07-30 | RBC Capital | Outperform | Maintains | |
| 2021-07-30 | SVB Leerink | Outperform | Maintains | |
| 2021-04-30 | SVB Leerink | Outperform | Maintains | |
| 2021-04-30 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-19 | Morgan Stanley | Overweight | Maintains | |
| 2021-04-01 | Bernstein | Market Perform | Outperform | Upgrade |
| 2021-03-30 | Redburn | Neutral | Buy | Upgrade |
| 2021-02-11 | SVB Leerink | Outperform | Maintains | |
| 2021-02-05 | Credit Suisse | Neutral | Maintains | |
| 2021-02-05 | SVB Leerink | Outperform | Maintains | |
| 2021-02-05 | Morgan Stanley | Overweight | Maintains | |
| 2021-01-19 | Morgan Stanley | Equal-Weight | Overweight | Upgrade |
| 2024-07-22 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2024-07-08 | Raymond James | Market Perform | Outperform | Upgrade |
| 2024-04-26 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-04-26 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2024-04-26 | TD Cowen | Buy | Buy | Maintains |
| 2024-04-26 | Needham | Hold | Reiterate | |
| 2024-04-24 | HSBC | Reduce | Hold | Upgrade |
| 2024-04-19 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-04-17 | UBS | Neutral | Neutral | Maintains |
| 2024-03-04 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-22 | Mizuho | Buy | Buy | Maintains |
| 2024-02-22 | Truist Securities | Buy | Hold | Downgrade |
| 2024-02-14 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-02-12 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-12 | Oppenheimer | Outperform | Outperform | Maintains |
| 2024-02-07 | Wells Fargo | Equal-Weight | Equal-Weight | Maintains |
| 2024-02-07 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-02-07 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2024-01-23 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-11-14 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-11-09 | Deutsche Bank | Hold | Initiate | |
| 2023-09-08 | B of A Securities | Neutral | Buy | Upgrade |
| 2023-09-06 | Truist Securities | Buy | Buy | Reiterate |
| 2023-09-06 | HSBC | Reduce | Initiate | |
| 2023-08-04 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2023-08-04 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-24 | Piper Sandler | Overweight | Overweight | Maintains |
| 2023-07-24 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2023-07-24 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-07-20 | Cantor Fitzgerald | Neutral | Neutral | Maintains |
| 2023-07-11 | Morgan Stanley | Equal-Weight | Equal-Weight | Reiterate |
| 2023-07-11 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2023-06-23 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2023-05-16 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2023-05-01 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-04-28 | RBC Capital | Sector Perform | Maintains | |
| 2023-04-25 | RBC Capital | Sector Perform | Reiterate | |
| 2023-04-12 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-03-06 | RBC Capital | Sector Perform | Maintains | |
| 2023-02-14 | Mizuho | Buy | Maintains | |
| 2023-02-03 | SVB Leerink | Market Perform | Maintains | |
| 2023-02-03 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-02-03 | Piper Sandler | Overweight | Maintains | |
| 2023-01-24 | Morgan Stanley | Equal-Weight | Maintains | |
| 2023-01-19 | Piper Sandler | Overweight | Maintains | |
| 2023-01-18 | Barclays | Equal-Weight | Maintains | |
| 2023-01-03 | Wells Fargo | Equal-Weight | Maintains | |
| 2016-04-29 | Maxim Group | Buy | Hold | Downgrade |
| 2016-04-29 | Citigroup | Buy | Maintains | |
| 2016-04-26 | Credit Suisse | Outperform | Maintains | |
| 2024-07-01 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-06-20 | Baird | Neutral | Neutral | Maintains |
| 2024-06-14 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-04-29 | Barclays | Equal-Weight | Equal-Weight | Maintains |
| 2020-12-16 | Credit Suisse | Neutral | Maintains | |
| 2020-11-24 | Truist Securities | Buy | Initiate | |
| 2020-11-06 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2020-11-03 | Morgan Stanley | Equal-Weight | Reiterate | |
| 2020-10-29 | BMO Capital | Market Perform | Maintains | |
| 2020-10-29 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2020-10-29 | Piper Sandler | Overweight | Maintains | |
| 2020-10-29 | Wells Fargo | Equal-Weight | Maintains | |
| 2020-10-29 | SVB Leerink | Outperform | Maintains | |
| 2020-10-28 | UBS | Neutral | Initiate | |
| 2020-09-18 | RBC Capital | Outperform | Maintains | |
| 2020-09-15 | Maxim Group | Hold | Buy | Upgrade |
| 2020-09-15 | RBC Capital | Outperform | Maintains | |
| 2020-09-14 | SVB Leerink | Outperform | Maintains | |
| 2020-09-10 | Oppenheimer | Outperform | Maintains | |
| 2020-08-20 | Truist Securities | Hold | Maintains | |
| 2020-08-19 | Piper Sandler | Overweight | Maintains | |
| 2020-08-19 | Cantor Fitzgerald | Overweight | Maintains | |
| 2020-07-31 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-07-31 | Credit Suisse | Neutral | Maintains | |
| 2020-07-20 | Credit Suisse | Underperform | Neutral | Upgrade |
| 2020-07-15 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-05-26 | SunTrust Robinson Humphrey | Sell | Hold | Upgrade |
| 2020-05-21 | Cowen & Co. | Outperform | Initiate | |
| 2020-05-01 | Morgan Stanley | Equal-Weight | Maintains | |
| 2020-05-01 | Oppenheimer | Outperform | Maintains | |
| 2020-05-01 | SVB Leerink | Market Perform | Maintains | |
| 2020-05-01 | Raymond James | Outperform | Market Perform | Downgrade |
| 2020-05-01 | SunTrust Robinson Humphrey | Hold | Sell | Downgrade |
| 2020-05-01 | JP Morgan | Overweight | Neutral | Downgrade |
| 2020-04-29 | CFRA | Sell | Maintains | |
| 2020-04-27 | UBS | Buy | Neutral | Downgrade |
| 2020-04-20 | BMO Capital | Outperform | Market Perform | Downgrade |
| 2020-04-20 | Wells Fargo | Overweight | Equal-Weight | Downgrade |
| 2020-04-17 | Baird | Neutral | Outperform | Upgrade |
| 2020-04-17 | CFRA | Hold | Sell | Downgrade |
| 2020-04-07 | Cantor Fitzgerald | Overweight | Reiterate | |
| 2020-03-20 | Piper Sandler | Neutral | Overweight | Upgrade |
| 2020-03-19 | Wells Fargo | Overweight | Maintains | |
| 2020-03-18 | DZ Bank | Hold | Buy | Upgrade |
| 2020-03-09 | RBC Capital | Top Pick | Outperform | Downgrade |
| 2020-02-28 | DZ Bank | Buy | Hold | Downgrade |
| 2020-02-27 | Barclays | Underweight | Initiate | |
| 2020-02-06 | Bernstein | Outperform | Market Perform | Downgrade |
| 2020-02-05 | Credit Suisse | Underperform | Maintains | |
| 2020-02-05 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2020-02-05 | B of A Securities | Neutral | Maintains | |
| 2020-01-21 | Guggenheim Securities | Buy | Neutral | Downgrade |
| 2019-12-20 | Wells Fargo | Overweight | Maintains | |
| 2019-12-13 | Credit Suisse | Neutral | Underperform | Downgrade |
| 2019-11-12 | SunTrust Robinson Humphrey | Hold | Initiate | |
| 2019-11-05 | Wells Fargo | Outperform | Maintains | |
| 2019-10-25 | Oppenheimer | Outperform | Maintains | |
| 2019-10-25 | Maxim Group | Buy | Hold | Downgrade |
| 2019-10-25 | BMO Capital | Outperform | Maintains | |
| 2019-10-25 | Raymond James | Strong Buy | Maintains | |
| 2019-08-19 | Wells Fargo | Outperform | Initiate | |
| 2019-07-31 | Credit Suisse | Neutral | Maintains | |
| 2019-07-31 | Raymond James | Strong Buy | Maintains | |
| 2019-07-29 | RBC Capital | Outperform | Top Pick | Upgrade |
| 2019-07-15 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2019-05-28 | Goldman Sachs | Neutral | Sell | Downgrade |
| 2019-05-23 | Citigroup | Neutral | Buy | Upgrade |
| 2019-05-21 | Credit Suisse | Neutral | Initiate | |
| 2019-04-26 | Bernstein | Outperform | Initiate | |
| 2019-04-17 | Longbow Research | Buy | Neutral | Downgrade |
| 2019-04-10 | UBS | Neutral | Buy | Upgrade |
| 2019-03-15 | BMO Capital | Outperform | Initiate | |
| 2019-02-12 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2019-02-12 | Citigroup | Buy | Neutral | Downgrade |
| 2019-02-12 | Wells Fargo | Outperform | Market Perform | Downgrade |
| 2019-01-03 | Oppenheimer | Perform | Outperform | Upgrade |
| 2018-12-19 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-10-26 | Raymond James | Strong Buy | Strong Buy | Maintains |
| 2018-10-26 | Cantor Fitzgerald | Overweight | Overweight | Maintains |
| 2018-10-26 | PiperJaffray | Overweight | Neutral | Downgrade |
| 2018-10-01 | Cantor Fitzgerald | Overweight | Initiate | |
| 2018-07-26 | Baird | Outperform | Neutral | Downgrade |
| 2018-07-26 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-06-28 | Raymond James | Strong Buy | Initiate | |
| 2018-06-19 | Baird | Outperform | Outperform | Maintains |
| 2018-05-02 | Barclays | Overweight | Overweight | Maintains |
| 2018-05-02 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-04-19 | Longbow Research | Neutral | Buy | Upgrade |
| 2018-03-06 | Barclays | Overweight | Overweight | Maintains |
| 2018-02-08 | BMO Capital | Outperform | Market Perform | Maintains |
| 2018-02-08 | Benchmark | Hold | Buy | Upgrade |
| 2018-02-07 | Leerink Swann | Market Perform | Market Perform | Maintains |
| 2018-02-07 | Bank of America | Neutral | Neutral | Maintains |
| 2018-02-07 | Morgan Stanley | Equal-Weight | Equal-Weight | Maintains |
| 2018-01-30 | Citigroup | Neutral | Buy | Upgrade |
| 2018-01-26 | Jefferies | Hold | Buy | Upgrade |
| 2018-01-16 | Wells Fargo | Market Perform | Outperform | Upgrade |
| 2017-12-20 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2017-11-30 | Maxim Group | Hold | Buy | Upgrade |
| 2017-11-13 | Argus | Buy | Hold | Downgrade |
| 2017-10-30 | Benchmark | Buy | Hold | Downgrade |
| 2017-10-27 | BMO Capital | Outperform | Maintains | |
| 2017-10-19 | Leerink Swann | Market Perform | Maintains | |
| 2017-10-06 | Morgan Stanley | Equal-Weight | Maintains | |
| 2017-10-05 | Oppenheimer | Perform | Initiate | |
| 2017-10-05 | Leerink Swann | Market Perform | Maintains | |
| 2017-10-04 | Bank of America | Neutral | Maintains | |
| 2017-09-15 | RBC Capital | Outperform | Initiate | |
| 2017-08-31 | Argus | Hold | Buy | Upgrade |
| 2017-08-29 | Credit Suisse | Outperform | Maintains | |
| 2017-07-26 | Redburn | Buy | Initiate | |
| 2017-06-23 | Deutsche Bank | Buy | Initiate | |
| 2017-03-09 | UBS | Buy | Neutral | Downgrade |
| 2017-02-08 | Citigroup | Buy | Neutral | Downgrade |
| 2016-12-01 | Summit Redstone Partners | Hold | Initiate | |
| 2016-11-14 | Stifel Nicolaus | Buy | Initiate | |
| 2016-11-08 | Mizuho | Buy | Initiate | |
| 2016-11-02 | BMO Capital | Market Perform | Outperform | Upgrade |
| 2016-10-05 | Jefferies | Buy | Maintains | |
| 2016-10-03 | RBC Capital | Outperform | Maintains | |
| 2016-09-27 | Leerink Swann | Outperform | Market Perform | Downgrade |
| 2016-09-22 | Berenberg | Buy | Initiate | |
| 2016-09-14 | Credit Suisse | Outperform | Maintains | |
| 2016-09-12 | Berenberg | Buy | Initiate | |
| 2016-09-06 | Jefferies | Hold | Buy | Upgrade |
| 2016-08-31 | Jefferies | Hold | Maintains | |
| 2016-07-29 | Argus | Buy | Hold | Downgrade |
| 2016-07-26 | Needham | Buy | Hold | Downgrade |
| 2016-06-01 | Gabelli & Co. | Buy | Initiate | |
| 2016-05-26 | Morgan Stanley | Equal-Weight | Maintains | |
| 2016-04-05 | BMO Capital | Market Perform | Initiate | |
| 2016-03-23 | Credit Suisse | Outperform | Maintains | |
| 2016-03-15 | Jefferies | Hold | Maintains | |
| 2016-02-25 | Citigroup | Buy | Initiate | |
| 2016-02-11 | Oppenheimer | Outperform | Initiate | |
| 2016-02-05 | Leerink Swann | Outperform | Initiate | |
| 2016-02-03 | Credit Suisse | Outperform | Maintains | |
| 2016-02-03 | Oppenheimer | Outperform | Maintains | |
| 2016-02-03 | Standpoint Research | Buy | Initiate | |
| 2016-01-20 | Credit Suisse | Outperform | Initiate | |
| 2016-01-15 | Bank of America | Underperform | Neutral | Upgrade |
| 2015-12-18 | Atlantic Equities | Neutral | Initiate | |
| 2015-11-05 | PiperJaffray | Neutral | Overweight | Upgrade |
| 2015-10-20 | Oppenheimer | Outperform | Maintains | |
| 2015-10-15 | Jefferies | Hold | Maintains | |
| 2015-10-02 | Morgan Stanley | Overweight | Equal-Weight | Downgrade |
| 2015-09-09 | Jefferies | Hold | Initiate | |
| 2015-07-29 | Deutsche Bank | Buy | Maintains | |
| 2015-07-29 | Barclays | Overweight | Maintains | |
| 2015-07-06 | Bank of America | Underperform | Maintains | |
| 2015-06-05 | Longbow Research | Buy | Neutral | Downgrade |
| 2015-03-27 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2015-02-06 | Credit Suisse | Outperform | Neutral | Downgrade |
| 2015-02-05 | Citigroup | Buy | Maintains | |
| 2015-02-04 | UBS | Buy | Maintains | |
| 2015-01-06 | Barclays | Overweight | Initiate | |
| 2014-12-23 | Deutsche Bank | Buy | Maintains | |
| 2014-12-22 | Bank of America | Buy | Underperform | Downgrade |
| 2014-12-09 | Morgan Stanley | Equal-Weight | Maintains | |
| 2014-12-05 | JP Morgan | Overweight | Maintains | |
| 2014-11-10 | Nomura | Buy | Maintains | |
| 2014-10-31 | Edward Jones | Hold | Initiate | |
| 2014-10-29 | Nomura | Buy | Maintains | |
| 2014-10-15 | Raymond James | Outperform | Strong Buy | Upgrade |
| 2014-10-13 | FBR Capital | Outperform | Maintains | |
| 2014-09-19 | Citigroup | Buy | Maintains | |
| 2014-09-10 | Baird | Outperform | Neutral | Downgrade |
| 2014-08-08 | Raymond James | Outperform | Maintains | |
| 2014-07-24 | JP Morgan | Overweight | Maintains | |
| 2014-07-18 | Nomura | Buy | Maintains | |
| 2014-06-10 | Topeka | Buy | Maintains | |
| 2014-06-10 | Raymond James | Outperform | Maintains | |
| 2014-05-09 | Raymond James | Outperform | Maintains | |
| 2014-04-23 | Nomura | Buy | Maintains | |
| 2014-04-23 | Deutsche Bank | Buy | Maintains | |
| 2014-04-22 | Jefferies | Hold | Maintains | |
| 2014-04-15 | Longbow Research | Buy | Maintains | |
| 2014-04-14 | Wells Fargo | Buy | Maintains | |
| 2014-04-10 | Nomura | Buy | Maintains | |
| 2014-03-27 | Morgan Stanley | Equal-Weight | Initiate | |
| 2014-02-05 | Stifel Nicolaus | Buy | Maintains | |
| 2014-02-04 | Nomura | Buy | Maintains | |
| 2014-02-04 | Baird | Neutral | Outperform | Upgrade |
| 2014-01-28 | Deutsche Bank | Buy | Maintains | |
| 2014-01-08 | Nomura | Buy | Initiate | |
| 2014-01-06 | UBS | Buy | Maintains | |
| 2013-12-18 | JP Morgan | Overweight | Maintains | |
| 2013-11-26 | Jefferies | Hold | Maintains | |
| 2013-11-25 | Deutsche Bank | Buy | Maintains | |
| 2013-11-20 | Citigroup | Buy | Maintains | |
| 2013-11-11 | Raymond James | Strong Buy | Outperform | Downgrade |
| 2013-10-30 | BMO Capital | Outperform | Maintains | |
| 2013-10-11 | Longbow Research | Neutral | Buy | Upgrade |
| 2013-07-26 | Atlantic Equities | Neutral | Overweight | Upgrade |
| 2013-07-26 | Baird | Outperform | Neutral | Downgrade |
| 2013-06-26 | Sterne Agee | Buy | Maintains | |
| 2013-06-13 | Argus | Hold | Buy | Upgrade |
| 2013-06-11 | Sterne Agee | Buy | Maintains | |
| 2013-05-23 | Topeka | Buy | Initiate | |
| 2013-05-06 | Baird | Neutral | Outperform | Upgrade |
| 2013-04-23 | PiperJaffray | Overweight | Maintains | |
| 2013-04-22 | Morgan Stanley | Overweight | Maintains | |
| 2013-04-22 | Maxim Group | Buy | Maintains | |
| 2013-04-16 | Deutsche Bank | Buy | Maintains | |
| 2013-04-15 | Leerink Swann | Outperform | Maintains | |
| 2013-04-12 | UBS | Buy | Maintains | |
| 2013-04-08 | Blaylock Robert Van | Buy | Initiate | |
| 2013-04-04 | Credit Suisse | Outperform | Maintains | |
| 2013-03-18 | Citigroup | Buy | Maintains | |
| 2013-03-14 | Oppenheimer | Outperform | Maintains | |
| 2013-03-05 | PiperJaffray | Overweight | Maintains | |
| 2013-02-19 | Credit Suisse | Neutral | Outperform | Upgrade |
| 2013-02-05 | Atlantic Equities | Overweight | Neutral | Downgrade |
| 2013-02-05 | Stifel Nicolaus | Buy | Maintains | |
| 2013-02-05 | UBS | Buy | Maintains | |
| 2013-02-05 | Jefferies | Hold | Maintains | |
| 2013-01-30 | Deutsche Bank | Buy | Maintains | |
| 2013-01-30 | UBS | Buy | Maintains | |
| 2013-01-03 | Baird | Outperform | Initiate | |
| 2012-12-27 | Benchmark | Buy | Maintains | |
| 2012-12-18 | UBS | Buy | Maintains | |
| 2012-12-18 | Morgan Stanley | Overweight | Maintains | |
| 2012-12-17 | Sterne Agee | Neutral | Buy | Upgrade |
| 2012-12-14 | PiperJaffray | Overweight | Maintains | |
| 2012-12-04 | Barclays | Overweight | Maintains | |
| 2012-11-13 | Deutsche Bank | Buy | Maintains | |
| 2012-11-13 | Stifel Nicolaus | Buy | Maintains | |
| 2012-10-24 | Credit Suisse | Neutral | Maintains | |
| 2012-10-24 | BMO Capital | Outperform | Maintains | |
| 2012-10-24 | Jefferies | Hold | Maintains | |
| 2012-10-15 | Barclays | Overweight | Maintains | |
| 2012-10-08 | PiperJaffray | Overweight | Maintains | |
| 2012-10-03 | UBS | Buy | Maintains | |
| 2012-10-03 | Sterne Agee | Underperform | Maintains | |
| 2012-10-01 | Bernstein | Market Perform | Outperform | Upgrade |
| 2012-09-27 | Bank of America | Buy | Maintains | |
| 2012-09-19 | Deutsche Bank | Buy | Maintains | |
| 2012-09-17 | JP Morgan | Overweight | Maintains | |
| 2012-08-30 | UBS | Buy | Maintains | |
| 2012-08-28 | Jefferies | Hold | Maintains | |
| 2012-08-28 | Stifel Nicolaus | Buy | Maintains | |
| 2012-08-15 | Deutsche Bank | Buy | Maintains | |
| 2012-08-09 | Benchmark | Buy | Maintains | |
| 2012-08-02 | Barclays | Equal-Weight | Overweight | Upgrade |
| 2012-08-02 | Deutsche Bank | Buy | Maintains | |
| 2012-07-27 | Stifel Nicolaus | Buy | Maintains | |
| 2012-07-27 | Jefferies | Hold | Maintains | |
| 2012-02-10 | Morgan Stanley | Overweight | Initiate | |
| 2024-09-04 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-02-12 | Piper Sandler | Overweight | Overweight | Maintains |
| 2025-02-12 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-02-12 | Needham | Hold | Hold | Reiterate |
| 2025-03-27 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-09-11 | Piper Sandler | Overweight | Overweight | Maintains |
| 2024-11-18 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2024-10-04 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-03-05 | Wells Fargo | Overweight | Overweight | Maintains |
| 2025-03-05 | B of A Securities | Buy | Buy | Maintains |
| 2024-10-09 | JP Morgan | Overweight | Overweight | Maintains |
| 2025-01-29 | JP Morgan | Overweight | Overweight | Maintains |
| 2024-12-10 | B of A Securities | Buy | Reiterate | |
| 2024-12-10 | Oppenheimer | Outperform | Outperform | Maintains |
| 2025-03-11 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-02-18 | Deutsche Bank | Hold | Buy | Upgrade |
| 2024-12-11 | RBC Capital | Sector Perform | Sector Perform | Reiterate |
| 2024-12-11 | Cantor Fitzgerald | Neutral | Neutral | Reiterate |
| 2025-07-25 | Needham | Hold | Buy | Upgrade |
| 2025-04-25 | Morgan Stanley | Overweight | Overweight | Maintains |
| 2025-04-25 | Oppenheimer | Outperform | Outperform | Maintains |
| 2025-04-25 | Needham | Hold | Hold | Reiterate |
| 2025-08-08 | UBS | Neutral | Neutral | Maintains |
| 2025-08-08 | RBC Capital | Sector Perform | Sector Perform | Maintains |
| 2025-08-08 | Truist Securities | Hold | Buy | Upgrade |
| 2025-05-21 | Needham | Hold | Hold | Reiterate |
